Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
California Governor Gavin Newsom today signed the biggest prescription drug price bill of the year, intended to lower prescription drug prices for California consumers by hundreds of millions of dollars a year. During the first-ever health care bill signing event under the new Administration, Newsom signed AB 824
If you tuned in for the first five nights of the Democratic presidential debates, you might think “Medicare for All” and providing universal care are the only health care ideas Democrats have.
Support is dropping for Sen. Bernie Sanders "Medicare for All" health care plan, according to a poll released Tuesday.
House Speaker Nancy Pelosi’s drug prices plan would reduce Medicare spending by $345 billion over a seven-year period but could also impact the number of new drugs entering the market, according to an analysis from the Congressional Budget Office.
A decision in the latest court case to threaten the future of the Affordable Care Act could come as soon as this month. The ruling will come from the panel of judges in the 5th Circuit Court of Appeals, which heard oral arguments in the Texas v. Azar lawsuit.
The very day President Trump was sworn in — Jan. 20, 2017 — he signed an executive order instructing administration officials "to waive, defer, grant exemptions from, or delay" implementing parts of the Affordable Care Act, while Congress got ready to repeal and replace President Obama's signature health law.
The two presidential candidates who have most strenuously backed Medicare-for-all are scrambling to ease concerns that it would create higher costs for many middle-class Americans.
A new California law that reclassifies some independent contractors as employees, requiring they be offered a range of benefits and worker protections, will likely expand health insurance coverage in the state, health policy experts say.
It’s shocking how far pharmaceutical companies go to keep drug prices high. Take, for example, a tactic known as “pay for delay.” It allows pharmaceutical companies to keep cheaper generic versions of their drugs off of the market.
Issuers of stand-alone Medicare Part D prescription drug plans may pay much higher minimum sales compensation levels in 2020.